Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2020

View Archived Issues

New aryl formyl piperidine derivatives reversibly inhibiting MAGL for the treatment of depression

ASO approach fixes myelin

FMF is Mediterranean's SCD

GB-1874, a novel inhibitor of Wnt signaling with activity in models of CRC

Amgen presents first orally available Mcl-1 inhibitor, AMG-397

OncoSec Medical divulges expression vectors encoding nucleic acid sequences for cancer

SIAT patents anti-H7N9 fully human monoclonal antibody 2G3 for H7N9 viral infection

Japanese researchers report new immunosuppressants

Sunshine Lake Pharma presents CD19-targeting antibodies

AdAlta moves AD-214 into the clinic

Researchers identify claudin 18.2-targeting antibodies

FDA lifts partial clinical hold on pivotal phase II study of camidanlumab tesirine

Clinical study of desidustat for the management of COVID-19 approved in Mexico

EXOSC4 gene is tied to breast cancer progression and poor survival

Suzhou Kintor Pharmaceuticals studies lead c-Myc/MAX protein-protein interaction inhibitor

Results from phase II RELIEF study of BLU-5937 in refractory chronic cough

Phase III ASCENT study of Trodelvy meets primary and key secondary endpoints

First participant enrolled in phase I study of ANAVEX 3-71

GI goblet cells prevent GvHD after stem cell transplant

CSL Behring initiates phase II study of CSL-312 for respiratory distress in patients with COVID-19

FDA places clinical hold on MELANI-01 study

Dimerix advances understanding of DMX-700 in COPD

ADGRG1 promotes TNBC progression and is a therapeutic druggable target

Otonomy reports treatment response in phase I/II trial of OTO-313 for tinnitus

Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris

European Commission approves Enerzair Breezhaler for uncontrolled asthma

Immune Regulation and DynPort partner to advance IRL-201104 for COVID-19-related ARDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...